In a study by Zeng et al., low-dose berberine modulates the tumor microenvironment through the PI3K/HIF-1 pathway, overcoming radiation resistance in cervical cancer cells under low glucose and hypoxic conditions (133). The gene discussed is HIF1A; the disease is neoplasm.